CEM is proud to be a keynote speaker at APPS 2026, presenting the latest advances in automated, large-scale microwave peptide synthesis and their potential to transform peptide manufacturing.

Keynote Speaker

Jonathan M. Collins
VP Business Development
CEM Corporation

Presentation

State-of-the-Art Large Scale Microwave Peptide Synthesis

Jonathan Collins will present the latest developments in microwave instrumentation for the fully automated, walk-away production of peptides at >1 kg per batch, including applications to high-value therapeutic peptides such as semaglutide and tirzepatide.

The presentation will highlight recent advances in production-scale peptide synthesis, including:

• Increased production capacity and scale per batch.
• Optimization of crude peptide purity.
• Near elimination of wash solvent.
• Reduced amino acid equivalents.
• Significant reductions in overall production time.
• Fully automated, walk-away operation.

These results demonstrate the unique benefits of microwave peptide synthesis for large-scale manufacturing, providing a route to faster, more efficient and more sustainable production of increasingly complex peptide therapeutics.

Our peptide synthesis specialists will be available throughout the symposium to discuss your applications, answer technical questions, and demonstrate how CEM can help overcome your most challenging peptide synthesis workflows.

Whether you're producing your first peptide or routinely synthesizing complex, long-chain therapeutic peptides, we'll show you how CEM technology can help you work smarter, faster, and with greater confidence.

Learn more

---

---